Core Nuclear Holdings
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
48/100
Moderate Influence
$2.9M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door
Core Nuclear Holdings reported $2.9 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Labor
Dept of Interior
Centers for Medicare & Medicaid Services
US Trade Representative
Food & Drug Administration
US Senate
White House
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Akin Gump LLP | HCRMEDPHA+2 | 1 | $139K |
| 2020 Apr-Jun | Cassidy & Associates LLP | PHAPOS | 1 | $95K |
| 2020 Jul-Sep | Holland & Knight LLP | HCRGOVPOS+1 | 1 | $151K |
| 2020 Oct-Dec | BGR Group LLP | HCRMED | 1 | $100K |
| 2021 Jan-Mar | Brownstein Hyatt LLP | HCRPHAGOV+1 | 1 | $122K |
| 2021 Apr-Jun | Squire Patton Boggs LLP | MEDPHAGOV | 1 | $133K |
| 2021 Jul-Sep | Brownstein Hyatt LLP | GOVHCRMED | 1 | $143K |
| 2021 Oct-Dec | Brownstein Hyatt LLP | HCRGOVPHA+1 | 1 | $143K |